S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.32
+1.64
+9.83%
GERN · Geron Corporation
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$1.15
-0.09
(-7.66%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$1.15
$1.15
$1.24
52-WEEK RANGE
$1.15
$1.04
$2.01
What's happening
- GERN is down 7.66% today, trading at $1.15. — Live quote
- Volume today (247,981) is well below its 3-month average of 10,478,510. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.02 actual vs. $-0.01 estimated (-117.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 5
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
GERN
-6.06%
vs S&P 500
-18.84%
1-YEAR RETURN
GERN
-2.36%
vs S&P 500
-16.92%
6-MONTH RETURN
GERN
-26.63%
3-MONTH RETURN
GERN
-13.89%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.02
Est. $-0.01
MISS -117.4%
2026-04-26 (Q1 2026)
$-0.01
Est. $-0.02
BEAT +52.6%
2026-01-26 (Q4 2025)
$-0.02
Est. $-0.03
BEAT +38.1%
2025-10-26 (Q3 2025)
$-0.03
Est. $-0.03
BEAT +11.0%
Valuation Measures & Ratios
Enterprise Value4$964.5M
Forward P/E540.38
PEG Ratio6—
Price / Sales (TTM1)3.80
Price / Book73.76
EV4 / Revenue4.71
EV4 / EBITDA2052.14
Profit Margin-33.05%
Operating Margin-25.31%
Return on Equity (ROE8)-29.32%
Return on Assets (ROA9)-12.34%
Avg Volume (3M)10,478,510
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.07B | $540.8M | $844.6M | $1.15B | $1.05B |
| P/E | -19.37 | -9.28 | -10.42 | -8.85 | -6.24 |
| Price/Sales | 5.19 | 2.88 | 5.15 | 9.77 | 15.27 |
| Price/Book | 4.88 | 2.36 | 3.40 | 4.43 | 3.93 |
| EV/Revenue | 5.47 | 3.15 | 5.40 | 10.12 | 15.78 |
| ROE | -25.22% | -25.44% | -32.60% | -50.11% | -63.02% |
| ROA | -10.62% | -10.91% | -14.29% | -23.42% | -30.06% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short73,886,113
Change from Prior Settlement-10.57%
% of Float—
Days to Cover (Short Ratio)7.39
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 17.2% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-01; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -33.0%. Finnhub fundamentals ↗
- Trailing 52-week price return is -2.4%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on GERN
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $57.5M | $51.8M | $47.2M | $49.0M | $39.6M | $28.3M | $882.0K | $304.0K |
| Operating income | -$12.5M | $158.0K | -$13.9M | -$12.5M | -$16.7M | -$28.2M | -$69.3M | -$56.1M |
| Net income | -$16.7M | -$3.6M | -$18.4M | -$16.4M | -$19.8M | -$26.4M | -$67.4M | -$55.4M |
| EPS (diluted) | $-0.02 | $-0.01 | $-0.03 | $-0.02 | $-0.03 | $-0.04 | $-0.10 | $-0.09 |
| EPS (basic) | $-0.02 | $-0.01 | $-0.03 | $-0.02 | $-0.03 | $-0.04 | $-0.10 | $-0.09 |
| Operating margin | -$22 | $0 | -$29 | -$25 | -$42 | -$100 | -$7.9K | -$18.5K |
| Net margin | -$29 | -$7 | -$39 | -$33 | -$50 | -$94 | -$7.6K | -$18.2K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $519.0M | $534.1M | $570.5M | $567.4M | $555.2M | $562.5M | $593.8M | $444.9M |
| Total liabilities | $300.4M | $305.0M | $344.7M | — | — | — | $313.5M | — |
| Stockholders' equity | $218.6M | $229.1M | $225.9M | $248.7M | $259.5M | $268.2M | $280.3M | $292.3M |
| Total current assets | $486.3M | $498.5M | $520.3M | $522.3M | $505.6M | $495.8M | $491.0M | $398.1M |
| Total current liabilities | $70.3M | $73.6M | $111.5M | $87.7M | $64.3M | $63.0M | $88.3M | $137.9M |
| Cash & equivalents | $62.6M | $68.9M | $77.6M | $78.1M | $77.7M | $83.7M | $79.0M | $60.3M |
| Accounts receivable | $51.6M | $41.9M | $37.0M | $35.4M | $36.6M | $31.2M | $35.9M | $28.0M |
| Inventory | $123.6M | $133.3M | $116.6M | $95.4M | $69.1M | $56.2M | $38.7M | $20.3M |
| Property, plant & equipment | $1.1M | $1.0M | $884.0K | $973.0K | $1.2M | $1.1M | $1.3M | $1.6M |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Accounts payable | $8.8M | $12.7M | $11.3M | $11.1M | $8.2M | $8.0M | $8.6M | $13.7M |
| Accrued liabilities | $30.7M | $31.0M | $51.3M | $39.9M | $26.3M | $28.9M | $35.5M | $36.5M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | $71.6M |
| Long-term debt | $120.1M | $119.8M | $119.5M | $119.3M | $119.0M | $118.7M | $118.5M | $12.3M |
| Common stock & paid-in capital | $642.0K | $641.0K | $640.0K | $638.0K | $638.0K | $637.0K | $606.0K | $603.0K |
| Retained earnings | -$1.88B | -$1.86B | -$1.86B | -$1.83B | -$1.81B | -$1.79B | -$1.77B | -$1.75B |
| Accumulated other comprehensive income (loss) | -$339.0K | -$191.0K | $269.0K | $408.0K | $117.0K | $304.0K | $261.0K | $1.0M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$15.8M | -$62.9M | -$22.1M | -$13.6M | -$27.4M | -$48.0M | -$43.9M | -$58.9M |
| Investing cash flow | $8.3M | $51.9M | $21.1M | $13.3M | $20.3M | $52.4M | -$103.5M | -$554.0K |
| Financing cash flow | $1.4M | $2.4M | $378.0K | $542.0K | $1.1M | $256.0K | $166.2M | $3.6M |
| Free cash flow | — | — | — | — | — | — | -$43.8M | -$58.9M |
| Capital expenditures | — | — | — | — | — | — | -$141.0K | $0 |
| Share-based compensation | $4.9M | $4.9M | $5.8M | $6.7M | $6.8M | $7.4M | $6.8M | $6.9M |
| Change in accounts receivable | $8.9M | $4.9M | $1.6M | -$1.3M | $5.3M | -$4.6M | $7.7M | $27.1M |
| Change in inventory | -$3.4M | $16.7M | $21.2M | $26.3M | $12.9M | $17.5M | $17.7M | $19.5M |
| Change in accounts payable | -$3.9M | $1.5M | $3.0M | — | $194.0K | -$563.0K | $2.4M | — |
| Purchases of investments | $88.9M | $34.5M | $104.2M | $77.0M | $76.7M | $46.5M | $184.8M | $65.8M |
| Sales/maturities of investments | — | — | — | $90.3M | $97.2M | $98.9M | $81.1M | $65.3M |
| Debt issued | — | — | $0 | — | — | — | $121.1M | — |
| Debt repaid | — | — | $0 | — | — | — | $86.6M | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | $237.0K | $596.0K | $1.4M |
| Operating income | -$68.6M | -$173.7M | -$193.9M | -$138.6M | -$114.0M |
| Net income | -$83.5M | -$174.6M | -$184.1M | -$141.9M | -$116.1M |
| EPS (diluted) | $-0.13 | $-0.27 | $-0.32 | $-0.37 | $-0.35 |
| EPS (basic) | $-0.13 | $-0.27 | $-0.32 | $-0.37 | $-0.35 |
| Operating margin | — | — | -$81.8K | -$23.2K | -$8.2K |
| Net margin | — | — | -$77.7K | -$23.8K | -$8.3K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $570.5M | $593.8M | $394.1M | $190.6M | $226.0M |
| Total liabilities | $344.7M | $313.5M | $146.1M | $110.6M | $99.6M |
| Stockholders' equity | $225.9M | $280.3M | $247.9M | $80.0M | $126.4M |
| Total current assets | $520.3M | $491.0M | $341.3M | $180.2M | $187.2M |
| Total current liabilities | $111.5M | $88.3M | $108.1M | $76.7M | $45.5M |
| Cash & equivalents | $77.6M | $79.0M | $70.0M | $56.8M | $34.9M |
| Accounts receivable | $37.0M | $35.9M | — | — | — |
| Inventory | $116.6M | $38.7M | — | — | — |
| Property, plant & equipment | $884.0K | $1.3M | $1.2M | $793.0K | $650.0K |
| Other non-current assets | — | — | — | — | — |
| Accounts payable | $11.3M | $8.6M | $6.2M | $10.2M | $6.7M |
| Accrued liabilities | $51.3M | $35.5M | $40.3M | $33.1M | $29.8M |
| Deferred revenue (current) | — | — | — | — | — |
| Short-term debt | — | — | $46.9M | $20.9M | — |
| Long-term debt | $119.5M | $118.5M | $35.1M | $30.2M | $49.8M |
| Common stock & paid-in capital | $640.0K | $606.0K | $545.0K | $390.0K | $324.0K |
| Retained earnings | -$1.86B | -$1.77B | -$1.60B | -$1.41B | -$1.27B |
| Accumulated other comprehensive income (loss) | $269.0K | $261.0K | $185.0K | -$219.0K | -$173.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$111.0M | -$218.6M | -$167.7M | -$127.4M | -$95.6M |
| Investing cash flow | $107.2M | -$106.0M | -$180.3M | $62.1M | $71.9M |
| Financing cash flow | $2.3M | $334.4M | $362.0M | $87.3M | $48.6M |
| Free cash flow | — | -$219.3M | -$168.6M | -$127.8M | -$95.8M |
| Capital expenditures | — | $680.0K | $830.0K | $431.0K | $207.0K |
| Share-based compensation | $26.7M | $31.2M | $18.5M | $8.0M | $8.1M |
| Change in accounts receivable | $991.0K | $35.7M | $0 | — | — |
| Change in inventory | $77.9M | $38.0M | $0 | — | — |
| Change in accounts payable | $2.7M | $2.4M | -$4.0M | $3.5M | -$232.0K |
| Purchases of investments | $304.4M | $476.9M | $475.6M | $258.0M | $177.4M |
| Sales/maturities of investments | — | $371.6M | $296.1M | $320.5M | $248.0M |
| Debt issued | $0 | $121.1M | $29.7M | — | $24.9M |
| Debt repaid | $0 | $86.6M | $0 | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding GERN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-06-30 to 2026-09-30
Recent transactions
- Most recent: Spiegel Robert J. (Reporting person) — Grant / award of 6,351 shares on 2026-09-30.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Spiegel Robert J. | Reporting person | Grant / award | 2026-09-30 | 6,351 |
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 2026-02-18 | 27,500 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Spiegel Robert J. | Reporting person | Grant / award | 6,351 | $1.23 |
| 2026-06-30 | Spiegel Robert J. | Reporting person | Grant / award | 6,103 | $1.28 |
| 2026-03-31 | Spiegel Robert J. | Reporting person | Grant / award | 5,243 | $1.49 |
| 2026-02-18 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 27,500 | $0.00 |
| 2026-02-18 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Open market sale | 9,855 | $1.94 |
| 2025-12-31 | Spiegel Robert J. | Reporting person | Grant / award | 5,918 | $1.32 |
| 2025-09-30 | Spiegel Robert J. | Director | Grant / award | 5,702 | $1.37 |
| 2025-06-30 | Spiegel Robert J. | Director | Grant / award | 5,540 | $1.41 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:30 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-01 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-05-27 | 8-K | 2026-05-20 | View on SEC.gov → |
| 2026-05-26 | 4 | 2026-05-20 | View on SEC.gov → |
| 2026-05-26 | 4 | 2026-05-20 | View on SEC.gov → |
| 2026-05-26 | 4 | 2026-05-20 | View on SEC.gov → |
| 2026-05-26 | 4 | 2026-05-20 | View on SEC.gov → |
| 2026-05-26 | 4 | 2026-05-20 | View on SEC.gov → |
| 2026-05-06 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-04-14 | 4 | 2026-04-13 | View on SEC.gov → |
Recent news
Headlines about GERN (Geron Corporation). Links open the publisher — we don’t host full articles.
-
Geron Corporation to Report Third Quarter 2026 Financial Results on November 4, 2026
Quiver Quantitative · 2026-10-21 -
Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026
Yahoo · 2026-10-21 -
Geron reports USD 57.48 million revenue: Geron stock sits 39.30 percent below its high
AD HOC NEWS · 2026-10-20 -
Geron Corporation (GERN) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo · 2026-10-19 -
Five analysts place USD 4.25 target on Geron stock
AD HOC NEWS · 2026-10-17 -
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia
Yahoo · 2026-10-12 -
Geron Q2 2026 Earnings Call: Complete Transcript
Benzinga · 2026-10-08
No headlines in this category right now — try “All”.